C. Monnerat

发表

Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer.

S. Novello, R. Henriksson, E. Raymond, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer.

S. Novello, R. Henriksson, E. Raymond, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Predicting species distributions from checklist data using site‐occupancy models

M. Kéry, C. Monnerat, B. Gardner, 2010 .

BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma

Jean-Marc Guinebretière, Alain Spatz, G. Lenoir, 2007, Familial Cancer.

Genetic predisposition to breast and ovarian cancer

P. Chappuis, L. Perey, C. Monnerat, 2017 .

A case of Muir-Torre syndrome associated with mucinous hepatic cholangiocarcinoma and a novel germline mutation of the MSH2 gene

P. Hutter, C. Monnerat, M. Vernez, 2006, Familial Cancer.

Long-term tolerability of the BRAF inhibitor vemurafenib in patients with metastatic melanoma: current study data and real-life observations

A. Wicki, C. Monnerat, V. Spataro, 2014, memo - Magazine of European Medical Oncology.

Small cell lung cancer: state of the art and future perspectives.

R. Stupp, S. Leyvraz, A. Turrisi, 2004, Lung cancer.

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?

P. Chappuis, C. Monnerat, M. Katapodi, 2020, PloS one.

Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer.

C. Monnerat, T. le Chevalier, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years

P. Chappuis, S. Merajver, C. Monnerat, 2021, Cancers.

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma.

S. Novello, E. Raymond, J. Armand, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose reduction of epoetin-alpha in the prevention of chemotherapy-induced anaemia

S. Leyvraz, C. Monnerat, M. Pless, 2010, Supportive Care in Cancer.

Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization?

C. Monnerat, J. Delaloye, J. Delaloye, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband–Provider and Proband–Family Communication in Hereditary Breast and Ovarian Cancer

P. Chappuis, C. Monnerat, M. Katapodi, 2022, Journal of personalized medicine.

[Homocysteine and venous thromboembolism].

D. Hayoz, C. Monnerat, 1997, Schweizerische medizinische Wochenschrift.

Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort

P. Chappuis, C. Monnerat, G. Fink, 2022, Journal of personalized medicine.

Different roles of concurring climate and regional land-use changes in past 40 years’ insect trends

F. Herzog, F. Korner‐Nievergelt, K. Bollmann, 2022, Nature communications.

Recent changes in distribution of dragonflies in Switzerland (Odonata)

C. Monnerat, Y. Gonseth, 2003 .

A cost-effective algorithm for hereditary nonpolyposis colorectal cancer detection.

F. Bosman, J. Benhattar, C. Monnerat, 2006, American journal of clinical pathology.

Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53

J. Beckmann, A. Pica, C. Monnerat, 2011, Familial Cancer.

Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop

N. Probst-Hensch, P. Chappuis, Z. Ademi, 2019, Public Health Genomics.

Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations

P. Chappuis, C. Monnerat, O. Pagani, 2014, Genetics in Medicine.

Phase II Study of Pemetrexed-Gemcitabine Combination in Patients with Advanced-Stage Non-Small Cell Lung Cancer

C. Obasaju, D. Ettinger, K. Kelly, 2004, Clinical Cancer Research.

Using a Tailored Digital Health Intervention for Family Communication and Cascade Genetic Testing in Swiss and Korean Families With Hereditary Breast and Ovarian Cancer: Protocol for the DIALOGUE Study

P. Chappuis, Sung-Won Kim, H. Park, 2020, JMIR research protocols.

End points for new agents in induction chemotherapy for locally advanced head and neck cancers.

J. Bourhis, E. Raymond, C. Monnerat, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Owlflies from Jordan (Neuroptera, Ascalaphidae)

C. Monnerat, L. Ábrahám, 2020 .

European Red List of Grasshoppers, Crickets and Bush-crickets

Correas, P. Fontana, C. Monnerat, 2016 .

Phenological and elevational shifts of plants, animals and fungi under climate change in the European Alps

S. Wipf, C. Rixen, Y. Vitasse, 2021, Biological reviews of the Cambridge Philosophical Society.

A rare case of prednimustine-induced myoclonus.

S. Leyvraz, C. Monnerat, M. Gander, 1997, Journal of the National Cancer Institute.

Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort

N. Probst-Hensch, P. Chappuis, C. Monnerat, 2022, Cancers.

ARTICLE Predicting species distributions from checklist data using site-occupancy

M. Kéry, C. Monnerat, B. Gardner, 2010 .

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.

C. Sessa, Joshua A. Bauer, C. Monnerat, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Range, distribution, field identification, behaviour and exuvia description of Orthetrum ransonnetii (Odonata: Libellulidae)

C. Monnerat, J. Boudot, A. Corso, 2020, Odonatologica.

[Zd 1839 "Iressa"].

E. Raymond, J. Armand, C. Monnerat, 2000, Bulletin du cancer.